Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2020-06-18 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于注销部分募集资金专户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the cancellation of a portion of the company's fundraising special accounts. It details the background of the fundraising, the management and use of the funds, and the decision to terminate certain investment projects and reallocate remaining funds to permanent working capital. The document is relatively short (1974 characters) and serves as a formal notice to shareholders and the public about changes in the use and management of previously raised capital. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is clearly an update on capital management activities related to fundraising. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-06-18 Chinese
2019年度权益分派实施的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from a company regarding the implementation of its 2019 annual equity distribution plan, including cash dividends and stock transfers. It details the dividend amount, stock split, record dates, and shareholder eligibility. The document is titled as an "implementation announcement" and contains no financial statements or detailed financial analysis. It is relatively short (2606 characters) and serves to inform shareholders of the dividend distribution and related corporate actions following approval at the annual general meeting. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2020-06-09 Chinese
关于特定股东股份减持计划时间过半的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a specific shareholder's share reduction plan, detailing the number of shares reduced, the timing, and compliance with relevant regulations. It includes tables showing shareholding before and after the reduction and confirms no violation of laws or company governance. The document is not a financial report, earnings release, or management discussion but a regulatory announcement about shareholding changes by a major shareholder. This fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or announcement of a report publication.
2020-06-08 Chinese
关于特定股东股份减持计划时间过半的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of a specific shareholder's plan to reduce their shareholding in the company. It details the amount of shares reduced, the timing, and compliance with relevant regulations. There is no financial report, earnings data, or management discussion. The document is focused on shareholding changes by a major shareholder but does not indicate a change in control or a new major shareholding notification crossing thresholds. It is a formal disclosure about a shareholder's reduction plan progress, which fits best under the category of Transaction in Own Shares (POS), as it reports on the company's shares being sold by a shareholder.
2020-05-27 Chinese
关于部分限制性股票回购注销完成的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the completion of a repurchase and cancellation of restricted shares by the company. It details the number of shares repurchased, the price, the approval process, and the impact on share capital. The document is relatively short (3799 characters) and focuses on a specific corporate action related to share repurchase and cancellation. It does not contain financial statements or comprehensive financial data, nor is it a report or presentation. This fits the category of a Transaction in Own Shares (POS), which covers company buybacks or sales of its own shares.
2020-05-22 Chinese
关于与安进达成靶向药物临床研究合作的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Xiamen Aide Biomedical Technology Co., Ltd. regarding a clinical research cooperation agreement with Amgen Inc. It details the nature of the cooperation, the parties involved, and the expected impact on the company. The text includes no financial statements, no quarterly or annual financial data, no management discussion of financial results, nor any regulatory certifications or voting results. It is a corporate announcement about a business collaboration, not a financial report or regulatory filing. The document length is about 2078 characters, which is relatively short and typical for an announcement. Therefore, the most appropriate classification is a Regulatory Filing (RNS), which serves as a general category for miscellaneous corporate announcements that do not fit other specific categories.
2020-05-22 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.